Abstract 684: DT-9045, a Novel PAR2 Inhibitor with Best-in-class Properties That Reduces Resistance to Both EGFR-targeting Therapies and Immunotherapy in Oncology Models Thibaut Brugat, Maleck Kadiri, Samya Aouad,Anne-Laure Blayo, Baptiste Rugeri, Antoine Mousson, Aurélie Janvier,Edith Steinberg,Luc Baron, Mandy Recolet, Xavier Wirth, Maria Jesus Garcia-Leon,Quentin Ruet,Meriem Semache,Laurent Sabbagh,Orphée Blanchard,Christel Franchet,Stanislas Mayer,John Stagg,Nathalie Lenne,Stephan SchannCancer Research（2024）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
